LATS2 deficiency, for instance, has been studied in several cancers including glioma (Kawahara et al., 2008; Guo et al., 2017, 2019; Ye et al., 2017; Jin et al., 2018; Pan et al., 2018; Shi et al., 2018, 2019; He et al., 2019; Hsu et al., 2019). The gene discussed is LATS2; the disease is central nervous system cancer.